Login to Your Account



Other News To Note


Friday, July 12, 2013
• Prometic Life Sciences Inc., of Laval, Quebec, said lead candidate PBI-4050 is set to start clinical testing in September.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription